Sex Differences and Predictors of Anti-osteoporosis Medication Use in the 12 months After Hip Fracture Surgery in Adults 65 or Older

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2024 Aug 2

PMID 39093438

Authors

Jennifer M Kirk

Alan M Rathbun

Ann L Gruber-Baldini

Marc C Hochberg

Jay Magaziner

Michelle D Shardell

Denise Orwig

Affiliations

Soon will be listed here.

Abstract

Purpose: This study evaluates sex differences and predictors of anti-osteoporosis medication (AOM) use following a hip fracture, with a focus on older men who exhibit higher mortality rates post-fracture compared to women over the age of 65.

Methods: Participants included 151 men and 161 women aged 65 and older with hip fractures. The outcome, AOM use, was assessed at baseline (≤ 22 days of hospitalization) and at 2, 6, and 12 months post-hip fracture. Generalized estimating equations (GEE) modeled sex differences and predictors of AOM use during the year post-fracture in 255 participants with complete baseline data and ≥ 1 follow-up observation.

Results: Of the 312 participants, only 53 used AOM at baseline, and 35 initiated use during follow-up. In the unadjusted GEE model, AOM use was significantly less likely in men (OR = 0.42; 95% CI, 0.22-0.78) compared to women. For both men and women, baseline use of AOM was a significant predictor (OR = 28.3; 95% CI, 5.4-148.0 vs. 41.6; 95% CI, 14.0-123.0). The other significant predictors by sex were osteoporosis diagnosis (OR = 3.19; 95% CI, 1.16-8.77) and minimal alcohol use (OR = 3.26; 95% CI, 1.34-7.94) for women versus age (OR = 1.09; 95% CI, 1.01-1.18) for men.

Conclusion: In older adults with hip fractures, AOM use is low over the year post-fracture and men are less likely to report AOM use compared to women which has implications for important sex differences in predictors of use. Further research is needed to address overall disparities and sex differences in AOM use.

References

Byszewski A, Lemay G, Molnar F, Azad N, McMartin S . Closing the osteoporosis care gap in hip fracture patients: an opportunity to decrease recurrent fractures and hospital admissions. J Osteoporos. 2011; 2011:404969. PMC: 3184412. DOI: 10.4061/2011/404969. View

Ip T, Leung J, Kung A . Management of osteoporosis in patients hospitalized for hip fractures. Osteoporos Int. 2010; 21(Suppl 4):S605-14. PMC: 2974929. DOI: 10.1007/s00198-010-1398-8. View

Brauer C, Coca-Perraillon M, Cutler D, Rosen A . Incidence and mortality of hip fractures in the United States. JAMA. 2009; 302(14):1573-9. PMC: 4410861. DOI: 10.1001/jama.2009.1462. View

Rathbun A, Shardell M, Orwig D, Hebel J, Hicks G, Beck T . Differences in the trajectory of bone mineral density change measured at the total hip and femoral neck between men and women following hip fracture. Arch Osteoporos. 2016; 11:9. PMC: 4983447. DOI: 10.1007/s11657-016-0263-6. View

Stevens J, Rudd R . The impact of decreasing U.S. hip fracture rates on future hip fracture estimates. Osteoporos Int. 2013; 24(10):2725-8. PMC: 4717482. DOI: 10.1007/s00198-013-2375-9. View

Dobre R, Niculescu D, Petca R, Popescu R, Petca A, Poiana C . Adherence to Anti-Osteoporotic Treatment and Clinical Implications after Hip Fracture: A Systematic Review. J Pers Med. 2021; 11(5). PMC: 8146075. DOI: 10.3390/jpm11050341. View

Brown C, Starr A, Nunley J . Analysis of past secular trends of hip fractures and predicted number in the future 2010-2050. J Orthop Trauma. 2011; 26(2):117-22. DOI: 10.1097/BOT.0b013e318219c61a. View

Cooper C, Cole Z, Holroyd C, Earl S, Harvey N, Dennison E . Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int. 2011; 22(5):1277-88. PMC: 3546313. DOI: 10.1007/s00198-011-1601-6. View

Bassuk S, Murphy J . Characteristics of the Modified Mini-Mental State Exam among elderly persons. J Clin Epidemiol. 2003; 56(7):622-8. DOI: 10.1016/s0895-4356(03)00111-2. View

10.

Zanker J, Duque G . Osteoporosis in Older Persons: Old and New Players. J Am Geriatr Soc. 2018; 67(4):831-840. DOI: 10.1111/jgs.15716. View

11.

C Grossman D, Curry S, Owens D, Barry M, Caughey A, Davidson K . Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 319(15):1592-1599. DOI: 10.1001/jama.2018.3185. View

12.

Li N, Cornelissen D, Silverman S, Pinto D, Si L, Kremer I . An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis. Pharmacoeconomics. 2020; 39(2):181-209. PMC: 7867562. DOI: 10.1007/s40273-020-00965-9. View

13.

Teng E, Chui H . The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987; 48(8):314-8. View

14.

Curtis J, McClure L, Delzell E, Howard V, Orwoll E, Saag K . Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med. 2009; 24(8):956-62. PMC: 2710475. DOI: 10.1007/s11606-009-1031-8. View

15.

Charlson M, Szatrowski T, Peterson J, Gold J . Validation of a combined comorbidity index. J Clin Epidemiol. 1994; 47(11):1245-51. DOI: 10.1016/0895-4356(94)90129-5. View

16.

Kahwati L, Weber R, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M . Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018; 319(15):1600-1612. DOI: 10.1001/jama.2017.21640. View

17.

Alswat K . Gender Disparities in Osteoporosis. J Clin Med Res. 2017; 9(5):382-387. PMC: 5380170. DOI: 10.14740/jocmr2970w. View

18.

Rathbun A, Magaziner J, Shardell M, Yerges-Armstrong L, Orwig D, Hicks G . Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators. Osteoporos Int. 2017; 29(2):365-373. PMC: 5898436. DOI: 10.1007/s00198-017-4280-0. View

19.

Friedman S, Mendelson D . Epidemiology of fragility fractures. Clin Geriatr Med. 2014; 30(2):175-81. DOI: 10.1016/j.cger.2014.01.001. View

20.

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View